These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. The preteen visit: an opportunity for prevention. Campos-Outcalt D. J Fam Pract; 2006 Dec; 55(12):1054-6. PubMed ID: 17137541 [Abstract] [Full Text] [Related]
43. Recommendations for Use of Meningococcal Conjugate Vaccines in HIV-Infected Persons - Advisory Committee on Immunization Practices, 2016. MacNeil JR, Rubin LG, Patton M, Ortega-Sanchez IR, Martin SW. MMWR Morb Mortal Wkly Rep; 2016 Nov 04; 65(43):1189-1194. PubMed ID: 27811836 [Abstract] [Full Text] [Related]
44. Meningococcal B vaccine: new drug. The only vaccine against some serogroup B meningococci. Prescrire Int; 2008 Jun 04; 17(95):95-7. PubMed ID: 18623907 [Abstract] [Full Text] [Related]
45. Coverage of recommended vaccines in children at 7-8 years of age in Flanders, Belgium. Theeten H, Vandermeulen C, Roelants M, Hoppenbrouwers K, Depoorter AM, Van Damme P. Acta Paediatr; 2009 Aug 04; 98(8):1307-12. PubMed ID: 19432835 [Abstract] [Full Text] [Related]
56. Two versus three doses of a meningococcal C conjugate vaccine concomitantly administered with a hexavalent DTaP-IPV-HBV/Hib vaccine in healthy infants. Schmitt HJ, Steul KS, Borkowski A, Ceddia F, Ypma E, Knuf M. Vaccine; 2008 Apr 24; 26(18):2242-52. PubMed ID: 18407386 [Abstract] [Full Text] [Related]
57. Combination vaccine use and vaccination quality in a managed care population. Happe LE, Lunacsek OE, Marshall GS, Lewis T, Spencer S. Am J Manag Care; 2007 Sep 24; 13(9):506-12. PubMed ID: 17803364 [Abstract] [Full Text] [Related]
60. A prospective study of the effectiveness of the New Zealand meningococcal B vaccine. Kelly C, Arnold R, Galloway Y, O'Hallahan J. Am J Epidemiol; 2007 Oct 01; 166(7):817-23. PubMed ID: 17615088 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]